Literature DB >> 16147469

Arteriolization of capillaries and FGF-2 upregulation in skeletal muscles of patients with chronic peripheral arterial disease.

Oliver Baum1, Valentin Djonov, Murielle Ganster, Matthias Widmer, Iris Baumgartner.   

Abstract

OBJECTIVE: Microvascular changes in ischemic skeletal muscle are described derived from patients with long-lasting peripheral arterial disease (PAD).
METHODS: Skeletal muscles from the lower limb of 17 patients (obtained after amputation) with chronic PAD and 4 asymptomatic controls (obtained from biopsies after bypass surgery) were evaluated by electron microscopy and immunohistochemistry.
RESULTS: The capillaries in skeletal muscles of PAD patients were surrounded by a more than 1 microm-thick coat, which was positively stained for basement membrane pericapillary coat collagen type IV. Thickness of the coat correlated with presence of PAD (p < .0001), and less strongly with diabetes mellitus (p = .023) and age of patients (p = .019). The majority of the capillaries in skeletal muscles of PAD patients (71.1 +/- 15.3%) were covered with cells positive for smooth muscle cell actin (sma) as compared to samples from asymptomatic controls (22.8% +/- 9.6%; p < .0001) suggesting advanced arteriolization. Semiquantitative analysis revealed that patients with PAD demonstrate a higher expression of FGF-2 in capillary endothelial cells (67.8 +/- 17.5%) as compared to controls (10.2 +/- 8.4%; p < .0001), whereas VEGF immunoreactivity was only occasionally present in extravascular cells.
CONCLUSION: Thickened collagen type IV-positive basement membranes in combination with a significant increase in sma-coverage indicate arteriolization of capillaries characteristic for chronic PAD, what may be related to high FGF-2 expression in capillary endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16147469     DOI: 10.1080/10739680591003413

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  12 in total

Review 1.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

2.  Contrast-enhanced ultrasonography of skeletal muscles for type 2 diabetes mellitus patients with microvascular complications.

Authors:  Ye Song; Yuan Li; Pei-Jun Wang; Yuan Gao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  A low-cost, wireless near-infrared spectroscopy device detects the presence of lower extremity atherosclerosis as measured by computed tomographic angiography and characterizes walking impairment in peripheral artery disease.

Authors:  Matthew A Fuglestad; Hernan Hernandez; Yue Gao; Henamari Ybay; Molly N Schieber; Katyarina E Brunette; Sara A Myers; George P Casale; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2019-08-21       Impact factor: 4.268

4.  VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis.

Authors:  I Mark Olfert; Richard A Howlett; Peter D Wagner; Ellen C Breen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-04       Impact factor: 3.619

6.  Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat.

Authors:  Malgorzata Milkiewicz; Olga Hudlicka; Ruth Shiner; Stuart Egginton; Margaret D Brown
Journal:  J Physiol       Date:  2006-09-21       Impact factor: 5.182

7.  Skeletal myofiber VEGF is essential for the exercise training response in adult mice.

Authors:  Hamid Delavar; Leonardo Nogueira; Peter D Wagner; Michael C Hogan; Daniel Metzger; Ellen C Breen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

8.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

9.  Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease.

Authors:  Duy M Ha; Lauren C Carpenter; Panagiotis Koutakis; Stanley A Swanson; Zhen Zhu; Mina Hanna; Holly K DeSpiegelaere; Iraklis I Pipinos; George P Casale
Journal:  J Transl Med       Date:  2016-02-04       Impact factor: 5.531

10.  Systems Pharmacology of VEGF165b in Peripheral Artery Disease.

Authors:  Lindsay E Clegg; Vijay C Ganta; Brian H Annex; Feilim Mac Gabhann
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.